Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|November 6, 2004
Treatment of advanced non-small-cell lung cancer in special populationsRogerio C LilenbaumClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
The evolving role of cetuximab in non-small cell lung cancerRogerio C LilenbaumClinical Lung Cancer|January 11, 2005
Treatment of patients with advanced lung cancer and poor performance statusRogerio C LilenbaumJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
New horizons in chemotherapy: platforms for combinations in first-line advanced non-small cell lung cancerRogerio C LilenbaumCurrent Oncology Reports|July 16, 2010
Small cell lung cancer: past, present, and futureEstelamari Rodriguez, Rogerio C LilenbaumClinical Lung Cancer|December 17, 2008
New treatment strategies in patients with advanced non-small-cell lung cancer and performance status 2Estelamari Rodriguez, Rogerio C LilenbaumClinical Lung Cancer|November 11, 2009
Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP programAlan P Lyss, Rogerio C LilenbaumJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right PatientCarolyn J Presley, Cary P Gross, Rogerio C LilenbaumJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Prevalence of poor performance status in lung cancer patients: implications for researchRogerio C Lilenbaum, John Cashy, Thomas A Hensing, et al.Journal of the National Cancer Institute. Monographs|October 24, 2007
Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapyDavid Cella, Lynne Wagner, John Cashy, et al.Pageof 2